Dynavax (NASDAQ: DVAX) common stock set for removal from Nasdaq listing

Rhea-AI Filing Summary

Dynavax Technologies Corp. filed a Form 25 indicating that its common stock is being removed from listing and/or registration on the Nasdaq Stock Market LLC under Section 12(b) of the Securities Exchange Act of 1934. Nasdaq certifies that it has complied with its own rules and relevant SEC regulations to strike this class of securities from listing or withdraw its registration.

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-34207

Issuer:	DYNAVAX TECHNOLOGIES CORP
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	2100 Powell Street
	Suite 720
	Emeryville	CALIFORNIA	94608-1111
Telephone number:					+1 510 848-5100

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Common Stock

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2026-02-10	By	Tara Petta		AVP
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Dynavax (DVAX) disclose in this Form 25 filing?

Dynavax discloses that its common stock is being removed from listing and/or registration on the Nasdaq Stock Market LLC. Nasdaq certifies compliance with its rules and SEC regulation 17 CFR 240.12d2-2 for striking or withdrawing this class of securities.

Which Dynavax security is affected by this Nasdaq delisting notice?

The filing specifies that Dynavax’s affected security is its Common Stock. The notification confirms that this class of securities is being removed from listing and/or registration on the Nasdaq Stock Market LLC in accordance with SEC Rule 12d2-2 procedures.

Who is the exchange involved in Dynavax (DVAX) Form 25 removal?

The exchange involved is the Nasdaq Stock Market LLC. The document states that Nasdaq has complied with its rules and SEC Rule 12d2-2 in striking Dynavax’s common stock from listing and/or withdrawing its registration under Section 12(b) of the Exchange Act.

Which SEC rule governs Dynavax’s removal from Nasdaq listing?

The removal is governed by 17 CFR 240.12d2-2 under the Securities Exchange Act of 1934. The filing cites subsections (a), (b), and (c), noting Nasdaq’s and the issuer’s compliance with the procedures for delisting and withdrawal of registration.

Who signed the Nasdaq certification for Dynavax’s Form 25?

The certification was signed on behalf of Nasdaq Stock Market LLC by Tara Petta, identified as an AVP. The signature confirms Nasdaq believes it meets all requirements for filing the Form 25 for Dynavax’s common stock removal.

What company details are provided for Dynavax (DVAX) in this notice?

The notice lists Dynavax Technologies Corp.’s principal executive office at 2100 Powell Street, Suite 720, Emeryville, California 94608-1111, with telephone number +1 510 848-5100. These details identify the issuer associated with the Nasdaq listing removal.